organic compounds
Acta Crystallographica Section C
Crystal Structure
Communications
or affinity of ligands binding to enzymes or receptors (Patrick,
2009; King, 2002). Sunitinib, (1), is a conformationally
restricted clinically approved MRTKI (multi-receptor tyrosine
kinase inhibitor) anticancer drug, combining a 1H-indol-
ISSN 0108-2701
2
2
(3H)-one (oxindole) core with a Z-substituted 3-(1H-pyrrol-
-ylmethylidene) side chain (Fig. 1; Atkins et al., 2006). The
Seven 3-methylidene-1H-indol-2(3H)-
ones related to the multiple-receptor
tyrosine kinase inhibitor sunitinib
pyrrole NH group in (1) forms an intramolecular hydrogen
bond with the oxindole carbonyl group, evidenced in solution,
1
by H NMR spectroscopy, and in the cocrystal structure of (1)
bound to an RTK (receptor tyrosine kinase) (Mohammadi
et al., 1997). Compound (2a), a lead molecule in the design of
(1), exhibits biological activity towards kinases [IC50 =
0.39 mM, PDGF (platelet-derived growth factor)], whereas
the 1-methylpyrrole analogue (E)-(3b) exhibits drastically
reduced biological activity (IC50 > 100 mM) towards PDGF
(Sun et al., 1998; Boiadjiev & Lightner, 2003).
Given the strong correlation between stereochemistry and
kinase inhibitory action within this series of molecules, we
have undertaken a structural study of oxindole analogues in
the solid phase to complement the extensive prior studies
undertaken in solution (Sun et al., 1998). Our investigation of
compounds (2)–(4) by Raman and FT–IR spectroscopy
a
a
a
John Spencer, Babur Z. Chowdhry, Samiyah Hamid,
a
b
b
Andrew P. Mendham, Louise Male, *‡ Simon J. Coles
b
and Michael B. Hursthouse
a
School of Science, University of Greenwich at Medway, Central Avenue, Chatham,
b
Kent ME4 4TB, England, and EPSRC National Crystallography Service, School of
Chemistry, University of Southampton, Highfield, Southampton SO17 1BJ, England
Received 9 July 2009
Accepted 15 December 2009
Online 15 January 2010
(
(
Spencer et al., 2010), supported by theoretical calculations
Kausar et al., 2009; Bell et al., 2007), has been facilitated by
The solid-state structures of a series of seven substituted
3-methylidene-1H-indol-2(3H)-one derivatives have been
determined by single-crystal X-ray diffraction and are
compared in detail. Six of the structures {(3Z)-3-(1H-pyrrol-
structure determinations from single-crystal X-ray diffraction
analysis, reported here. The molecules selected for this study
can be subdivided into several categories:
i) heterocycle-substituted analogues (2), found to exist
exclusively as the Z isomer in solution;
ii) heterocycle-substituted analogues (3), found to exist
exclusively as the E isomer in solution;
iii) simple symmetrically substituted analogues (4) and (5),
obtained in order to provide a fingerprint region for the FT–
IR and Raman studies, especially (4a), given that the parent
methylidene compound (4d) is reported to be unstable in
solution (Rossiter, 2002).
Analogues (2)–(4) were synthesized by a standard Knoe-
venagel condensation of oxindole with a variety of aldehydes
2-ylmethylidene)-1H-indol-2(3H)-one, C H N O, (2a); (3Z)-
13 10 2
(
3
-(2-thienylmethylidene)-1H-indol-2(3H)-one, C H NOS,
1
3
9
(2b); (3E)-3-(2-furylmethylidene)-1H-indol-2(3H)-one mono-
(
hydrate, C H NO ꢀH O, (3a); 3-(1-methylethylidene)-1H-
1
3
9
2
2
indol-2(3H)-one, C H NO, (4a); 3-cyclohexylidene-1H-
1
1
11
(
0
indol-2(3H)-one, C H NO, (4c); and spiro[1,3-dioxane-2,3 -
4
1
15
0
indolin]-2 -one, C H NO , (5)} display, as expected, inter-
1
1
11
3
molecular hydrogen bonding (N—Hꢀ ꢀ ꢀO C) between the
H-indol-2(3H)-one units. However, methyl 3-(1-methylethyl-
idene)-2-oxo-2,3-dihydro-1H-indole-1-carboxylate, C H N-
1
13
13
O , (4b), a carbamate analogue of (4a) lacking an N—H
3
bond, displays no intermolecular hydrogen bonding. The
structure of (4a) contains three molecules in the asymmetric
unit, while (4b) and (4c) both contain two independent
molecules.
Comment
Conformational restriction is a useful tactic employed in
medicinal chemistry, which often leads to an improvement in
the biological properties of a molecule by reducing entropy
and contributing to enhanced binding to a receptor or enzyme.
This extends to the presence of a conformational blocker, such
as an ortho-substituent in biphenyl derivatives, which hinders
free rotation, or a strong hydrogen bond to ‘lock’ two groups
together into a favourable binding orientation. A strategically
placed double bond (E or Z isomer) in the molecule also falls
within this category, since it can drastically affect the activity
‡ Current address: School of Chemistry, University of Birmingham,
Edgbaston, Birmingham B15 2TT, England.
Figure 1
Examples of oxindoles tested for anticancer activity.
Acta Cryst. (2010). C66, o71–o78
doi:10.1107/S0108270109054134
# 2010 International Union of Crystallography o71